Global Blood Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLOBAL BLOOD THERAPS, and what generic alternatives to GLOBAL BLOOD THERAPS drugs are available?
GLOBAL BLOOD THERAPS has two approved drugs.
There are eleven US patents protecting GLOBAL BLOOD THERAPS drugs.
There are two hundred and fifty-six patent family members on GLOBAL BLOOD THERAPS drugs in forty countries and eleven supplementary protection certificates in ten countries.
Summary for Global Blood Theraps
| International Patents: | 256 |
| US Patents: | 11 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Global Blood Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET, FOR SUSPENSION;ORAL | 216157-001 | Dec 17, 2021 | RX | Yes | Yes | 9,447,071 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 9,447,071 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-002 | Oct 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Global Blood Theraps Drugs
Supplementary Protection Certificates for Global Blood Theraps Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2797416 | 2290032-8 | Sweden | ⤷ Sign Up | PRODUCT NAME: VOXELOTOR OR A TAUTOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/21/1622 20220215 |
| 2797416 | 122022000052 | Germany | ⤷ Sign Up | PRODUCT NAME: VOXELOTOR ODER EIN TAUTOMER ODER PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1622 20220214 |
| 2797416 | 22C1042 | France | ⤷ Sign Up | PRODUCT NAME: VOXELOTOR OU UN TAUTOMERE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/21/1622 20220215 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
